STAGE II LUNG CANCER AJCC V8

This early-stage trial tested whether adding immunotherapy drugs (durvalumab, monalizumab, or oleclumab) to radiation therapy is safe for people with locally advanced non-small cell lung cancer that cannot be removed by surgery. Twenty-six participants received different combinat…

This study looked at people with stage 2 or 3 non-small cell lung cancer that cannot be removed by surgery. Participants received standard chemotherapy along with different doses of proton beam radiation to find the most effective dose. The goal was to improve how long the cancer…

This study tested whether the immunotherapy drug pembrolizumab could prevent lung cancer from coming back in 45 people with early-stage lung cancer or high-risk lung nodules. Participants received the drug and were monitored for tumor response and survival. The goal was to see if…

This early-phase study tested a vaccine called CIMAvax-EGF in 20 people at high risk for lung cancer or survivors at risk of recurrence. The vaccine works by helping the body make antibodies against a protein that can fuel cancer growth. Researchers checked for side effects and m…

This study looked at heart changes in 24 people receiving radiation or chemo-radiation for lung or esophageal cancer that hadn't spread. Participants got a small heart monitor implanted to track heart problems that might otherwise go unnoticed. The goal was to better understand a…